NEW YORK (GenomeWeb) – Veracyte announced today that Medicare contractor Noridian has issued a draft local coverage determination (LCD) for its Percepta Bronchial Genomic Classifier.
Noridian, the nation’s largest Medicare Administrative Contractor (MAC), is one of four MACs (with Palmetto GBA, CGS, and WPS) in the national Molecular Diagnostic Services (MolDx) program from which Veracyte had anticipated receiving draft local coverage determinations for Percepta.